SNPMiner Trials by Shray Alag


SNPMiner Trials: Clinical Trial Report


Report for Clinical Trial NCT01175161

Developed by Shray Alag, 2019.
SNP Clinical Trial Gene

A Pilot Study Of A Randomized Trial Comparing Two Different Time Frames For Copper T380A Intrauterine Contraception Insertion; Immediately Postpartum Compared To 4-6 Weeks Postpartum In Lilongwe, Malawi

The purpose of this non-blinded randomized clinical trial is to pilot the design of a randomized clinical trial to be conducted in Malawi to investigate immediate postpartum insertion of the Copper T380 intrauterine contraceptive device (CuT380A-IUCD) compared to placement at the 6-week postpartum visit. The investigators hypothesize that it will be feasible to enroll 140 women into this study, and that women will find the 10 minute to 48 hour time frame for IUCD placement acceptable.

NCT01175161 Contraception Intrauterine Devices Pilot Study Africa

1 Interventions

Name: Copper T380A Intrauterine Device

Description: the Copper T380A IUD will be placed either 10 minutes to 48 hours postpartum, or 4-6 weeks postpartum.

Type: Device

Immediate postpartum IUD insertion 6 week postpartum IUD insertion


Primary Outcomes

Description: Estimate the time required to enroll 140 women into this study

Measure: Time

Time: 6 months

Secondary Outcomes

Description: Estimate the expulsion rate of the CuT380A-IUCD

Measure: Expulsion rates

Time: 6 months

Description: Assess patient and provider satisfaction when the CuT380A-IUCD is placed 10 minutes - 48-hours postpartum.

Measure: Satisfaction

Time: 6 months

Allocation: Randomized

Parallel Assignment


There is one SNP

SNPs


1 T380A

A Pilot Study Of A Randomized Trial Comparing Two Different Time Frames For Copper T380A Intrauterine Contraception Insertion; Immediately Postpartum Compared To 4-6 Weeks Postpartum In Lilongwe, Malawi. --- T380A ---



HPO Nodes